Inflammation is a complex response to diverse pathological conditions, resulting in negative rather than protective effects when uncontrolled. Orientin (Ori), a flavonoid component isolated from natural plants, possesses abundant properties. Thus, we aimed to discover the potential therapeutic effects of orientin on lipopolysaccharide‐ (LPS‐) induced inflammation in RAW 264.7 cells and the underlying mechanisms. In our studies, we evaluated the effects of Ori on proinflammatory mediator production stimulated by LPS, including tumor necrosis factor‐ (TNF‐) α, interleukin‐ (IL‐) 6, IL‐18, and IL‐1β, along with prostaglandin E2 (PGE2) and NO. Our data indicated that orientin dramatically inhibited the levels of these mediators. Consistent with these results, the expression levels of cyclooxygenase‐2 (COX‐2) and inducible nitric oxide synthase (iNOS) were also reduced. Further study demonstrated that such inhibitory effects of Ori were due to suppression of the nuclear factor‐kappa B (NF‐κB) pathway and nucleotide‐binding domain‐ (NOD‐) like receptor protein 3 (NLRP3) inflammasome activation, which may contribute to its anti‐inflammatory effects. Together, these findings show that Ori may be an effective candidate for ameliorating LPS‐induced inflammatory responses.
1 September 2021 in International Immunopharmacology